We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04811131
Recruitment Status : Terminated (Sponsor Decision)
First Posted : March 23, 2021
Last Update Posted : August 8, 2022
Information provided by (Responsible Party):
Arcutis Biotherapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 9, 2021
Actual Study Completion Date : August 9, 2021
Certification/Extension First Submitted : June 29, 2022